Do anything, become nothing – The Morning News
A new longitudinal study has found that adolescent cannabis use is associated with an increased risk of developing bipolar disorder and psychotic disorders later in life. These findings underscore the particular vulnerability of the developing brain to cannabis exposure, with age of onset identified as a clinically significant factor in downstream psychiatric outcomes.
Why this matters
Longitudinal evidence linking adolescent cannabis exposure to increased risk of bipolar and psychotic disorders reinforces the clinical importance of distinguishing pediatric and adult risk profiles when counseling patients. The neurodevelopmental vulnerability of the adolescent brain represents a distinct biological substrate, making age of initiation a critical variable in risk stratification. Clinicians should incorporate cannabis use screening and targeted anticipatory guidance into routine adolescent care, particularly given evolving legal landscapes that may normalize early-onset use.
Dr. Caplan take
“The data on adolescent cannabis exposure and psychiatric risk have been building for years, and this longitudinal work reinforces what I counsel families about consistently: the developing brain responds to cannabinoids in ways that are categorically different from the adult brain, and the earlier the exposure, the greater the potential for lasting neuropsychiatric consequences. This is not a reason to stigmatize cannabis as a medicine, but it is a clear clinical signal that age of onset is one of the most consequential variables we have in this space.”
#Cannabis #CannabisMedicine #ClinicalCannabis #MentalHealth #Safety #Research #Pediatrics #THC